NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Genre Technical Report Remove constraint Genre: Technical Report Copyright Copyright may apply Remove constraint Copyright: Copyright may apply

Search Results

2812. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

2813. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

2814. Tezepelumab for severe asthma: final report

2815. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

2816. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

2818. Aducanumab for Alzheimer’s disease: effectiveness and value